According to the most recent financial data from July 2025, the EPS for the trailing twelve months is $2.04. Cooper Companies's EPS for 2024 amounted to $1.97, marking an increase from $1.49 in 2023. During the quarterly period ending on Jul 31, 2025, COO's EPS stood at $0.49.
Cooper Companies had an annual EPS of $1.97, indicating an increase of 32.2% from $1.49 in 2023. The quarterly per-share earnings for the period ending Jul 31, 2025, was $0.49, indicating a 7.5% decrease from the same quarter last year. COO's 12-month EPS stands at $2.04 as of July 2025. Cooper Companies's annual EPS in 2023 stood at $1.49, a 23.6% decrease year-over-year.
During the last 12 months, Cooper Companies has seen an EPS growth of -7.5% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -49.1% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of -3.5%. A 10-year view shows that COO has seen an average EPS growth of 3.5% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| UTMD Utah Medical Products Inc | 15.46 | -13.5% | -0.7% | 0% |
| NVS Novartis AG | 17.17 | -17.2% | -17.9% | 2.9% |
| JNJ Johnson & Johnson | 17.9 | -57.9% | -9.7% | 0.4% |
| TFX Teleflex Inc | 25.28 | -80.3% | -47.6% | -31.7% |
| COO Cooper Companies Inc | 33.78 | 32.2% | -49.1% | -3.5% |
| BSX Boston Scientific Corp | 52.21 | 16.7% | 22.2% | -17.9% |
All data is based on quarterly TTM periods, unless otherwise specified.